Clinical trials: Mild Hypoxic Ischemic Encephalopathy of Newborn

Hypoxic-Ischemic Encephalopathy

Safety and Efficacy of Hypothermia to Treat Neonatal Hypoxic-Ischemic Encephalopathy

• Completed
• Age: Up to 6 hours
• Phase 3
• Medical device
• Results posted

The purpose of this study is to investigate the effectiveness and safety of selective head cooling (SHC) in neonatal hypoxic-ischemic encephalopathy (HIE).

Trial name

NCT00890409

Testing

Cooling cap (YJW608-04B)

Where

China

Volunteers

256 people

Sponsor

Fudan University